Frank Struyf

12PUBLICATIONS
49CO-AUTHORS
Innate immunityInfectious diseasesPredictive and prognostic markersMedical biotechnology diagnostics (incl. biosensors)Venereology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 29, 2025
Reactogenicity, safety, and immunogenicity of a quadrivalent seasonal influenza vaccine in adults aged 65 years and older: Phase 4 study results from India during December 2023-February 2024.

Vishal Jain, Frédéric Cauwberghs, Hanzhu Qian

|May 10, 2025
Comparison of vaccine-induced immune thrombocytopenia and thrombosis cases following two adenovirus-vectored COVID-19 vaccines.

Rian Van Rampelbergh, Sue Pavord, Luis Anaya-Velarde

|Nov 12, 2024
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.

Lindsay N Carpp, Ollivier Hyrien, Youyi Fong

|Nov 10, 2022
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial.

Youyi Fong, Adrian B McDermott, David Benkeser

|Feb 09, 2022
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.

Jerald Sadoff, Glenda Gray, An Vandebosch

|Jul 14, 2021
Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination.

Dan H Barouch, Kathryn E Stephenson, Jerald Sadoff

Pageof 2

Frequent Collaborators

5 joint publications

Hanneke Schuitemaker

4 joint publications

Lawrence Corey

2 joint publications

Mike Castro

2 joint publications

Nima S Hejazi